Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Inge Marie Svane

Clinical trials sponsored by Inge Marie Svane, explained in plain language.

Not yet recruiting 1

New immunotherapy combo eyed for rare eye cancer before surgery

Disease control Not yet recruiting

This early-stage trial tests whether giving two immunotherapy drugs (nivolumab and ipilimumab) before eye removal surgery is safe and doable for people with high-risk uveal melanoma, a rare eye cancer. About 15 participants will receive the drugs, then have their eye removed. Res…

Phase: PHASE1 • Sponsor: Inge Marie Svane • Aim: Disease control

Last updated Apr 30, 2026 15:52 UTC